What Happened?
Baltimore, MD-based GrayBug Appointed Justin Hanes as Chief Executive Officer
About the Company
GrayBug® is a platform drug delivery company that is developing proprietary controlled release technologies for ophthalmic pharmaceutical indications. The company`s lead product is a polymer-drug biomolecular conjugate for the treatment of neovascular diseases, including age-related macular degeneration (AMD). GrayBug also has a proprietary platform technology that allows sustained drug delivery into various compartments of the eye while minimizing inflammation common with current controlled release technologies applied to the eye.
About the Person
Justin Hanes is Chief Executive Officer at GrayBug. Previously, Justin held various senior HR leadership roles in the industry.
Info Source
News
Short Profile